[Application of VEGF165 plasmid in treatment of critical lower limb ischemia].

Unlabelled: In the study we assessed the clinical and histological benefits of gene therapy in no-option patients with critical lower limb ischemia.

Material And Methods: We administrated VEGF165 (Vascular Endothelial Growth Factor) plasmid to 10 patients. The plasmid was injected intramuscularly into lower limb.